BIOMAT Database Logo BIOMAT Database Logo

[Resistance to antitubercular drugs in Chile]. 1984

M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013307 Streptomycin An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis. Estreptomicina CEPA,Estreptomicina Clariana,Estreptomicina Normon,Strepto-Fatol,Strepto-Hefa,Streptomycin Grünenthal,Streptomycin Sulfate,Streptomycin Sulfate (2:3) Salt,Streptomycin Sulphate,Streptomycine Panpharma,Strepto Fatol,Strepto Hefa
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
Resistance to antitubercular drugs.
January 1998, Advances in experimental medicine and biology,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Acquired resistance of M tuberculosis to the antitubercular drugs in Chile from 1988 to 1991].
November 1993, Revista medica de Chile,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Primary resistance to antitubercular drugs].
June 1989, Medicina clinica,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Primary resistance to antitubercular drugs].
February 1990, Medicina clinica,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[BACTERIAL RESISTANCE TO SUBSIDIARY ANTITUBERCULAR DRUGS].
January 1964, Medicina,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
February 1998, Schweizerische medizinische Wochenschrift,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Study of primary resistance to antitubercular drugs in Galicia].
January 1994, Archivos de bronconeumologia,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Editorial: Primary resistance to antitubercular drugs in Puerto Rico].
November 1974, Boletin de la Asociacion Medica de Puerto Rico,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Surveillance of resistance to antitubercular drugs in Cuba, 2000-2009].
December 2011, Revista panamericana de salud publica = Pan American journal of public health,
M T Valenzuela, and G Scheel, and J Ponce, and R Lepe, and M Velasco, and P Valenzuela
[Method of measuring microbial resistance to secondary antitubercular drugs].
January 1966, Saishin igaku. Modern medicine,
Copied contents to your clipboard!